Our Climate Actions and Performance

As a pharmaceuticals manufacturer, Duopharma Biotech seeks to minimise as far as possible any negative footprint we have while putting in place systems and processes to create positive outcomes. Our Climate Performance-related initiatives cover carbon emissions and energy usage reduction, improving water management efficiency as well as reduction in waste generation. 


Carbon Emissions Management

The greenhouse gases (GHG) emitted by human activities have contributed to global warming and climate change such as intense droughts, rising sea levels, flooding and catastrophic storms, amongst others. At Duopharma, we constantly reviewing our mechanism to track and report GHG emissions (i.e. carbon emissions), and move towards carbon neutral pathway. To support this, we have set target to offset 10% of Scope 2 carbon emissions annually. In the long term, we aim to achieve Carbon Neutrality by 2030 and Net Zero Carbon Emissions by 2050.

Anchored by our 5-year ESG Strategy, we look at multiple ways to reduce our carbon emissions and energy consumption. Our Climate Roadmap outlines potential carbon and energy reduction initiatives that we plan to embark in the short, medium and long-term, and help us to strategise and prioritise our mitigation actions accordingly. This includes exploring renewable energy opportunities and implementing alternative clean energy i.e. Solar, Cooling, Heat & Power (CHP) for all sites to reduce emissions in the near future.

Our carbon and energy reduction initiatives:

  • Energy Audit
    • Duopharma has conducted Level 1 Energy Audit from January to April 2022. The audit was performed at all Duopharma’s major production facilities to understand our current energy consumption usage, and to identify potential energy saving opportunities for implementation.
  • Implementation of Energy Efficiency Initiatives
    • Installation of dual condensing units for air-conditioning system to improve heat rejection capability and increases unit’s efficiency, based on the recommendation from our energy audit.
    • Replacement of all old fluorescent tubes to light emitting diodes (LED) to ensure we use energy optimally.
    • Installation of split air-conditioner system for an efficient and cost effective usage. We also shut down the Air Handling Unit (AHU) and Dehumidifier during the night when they are not in use.
    • Moving forward, we are exploring the feasibility of implementing Solar Photovoltaic Rooftop System and to retrofit all aging equipment with new/ high-efficient equipment and system to reduce our energy consumption and carbon emissions.
  • Electric Vehicle (EV) Charger Installation
    • We lay the foundation for a smarter, reliable and emission-free mobility by installing EV Charger for our staff. The installation aims to promote green mobility and support reduction of our GHG Scope 3 emissions.

Efficient Water Management

Water is a pressing need in many areas of the world. Water scarcity may impose high risk to operations as water is needed to grow and process food, create energy, and serve industry for a continually growing population. At Duopharma, we believe the importance of comprehensive water management, which is managed through monitoring of water consumption, implementing water efficiency initiatives and proper management of effluents and wastewater to protect water resources.

At Duopharma, we believe the importance of comprehensive water management. We established water management plan for all three main manufacturing sites in Klang, Bangi and Glenmarie. The water management plan includes guidelines and procedures to monitor water consumption and recyling, proper management of effluents and wastewater (monitoring of effluent characteristics), and the implementation of water efficiency initiatives. The outcome of the monitoring (water usage and quality) are presented to the Management Committee on monthly basis, whereas effluent characteristics are presented to Environmental Performance Monitoring Committee (EPMC) every quarter.

Our water-related initiatives:

  • Water Audit and Water Efficiency Initiatives
    • Duopharma has conducted Preliminary Water Audit from August to September 2021. Following to the audit, we have implemented improvement initiatives to save unnecessary water loss by fixing water tap/pipe leakages, reducing toilet flush tank water level by 10%, and increasing the Cycle of Concentration (COC) of cooling tower. 
  • In-house Water Recycling 
    • At Duopharma we re-use treated waste water from purified water system for housekeeping and gardening purposes. We also use recycled water to reduce temperature of certain machines, such as autoclave.
  • Rainwater Harvesting
    • We have installed rainwater harvesting system, which includes two tanks that are able to store around 5,000 litres of rainwater each. The installation will help to reduce our dependency on natural water resources.
  • Green Cleaning – Using Bio-enzyme as cleaning agent
    • We reduce the usage of chemical cleaning agent for Heating, Ventilation, and Air Conditioning (HVAC), by replacing with bio-enzyme as an agent to wash the ducting and cooling element in HVAC. The bio-enzymatic cleaning are environmental friendly as it does not pollute the lakes and underground water.

Waste and Material Management

When waste is disposed of or recycled in a safe, ethical, and responsible manner, it helps reduce the negative impacts to the environment. Ensuring that waste and material management procedures are carried out responsibly and with regularity helps to avoid unnecessary waste generation. At Duopharma, we strive to ensure efficient use of materials, adopt best practices in waste disposal, strengthening our recycling efforts and ensuring compliance to relevant environmental laws and regulations throughout our operations.

Our waste management initiatives:

  • Scheduled Waste
    • Duopharma produce six types of scheduled waste, which are collected by licensed operators and disposed of according to regulations with proper disposal methods. We are environmentally responsible with our operations that we monitor and ensure proper management of scheduled waste, as guided by our Standard Operating Procedure. Training is provided by competent personnel to all departments involved in scheduled waste management.
  • Recycling of Non-Scheduled Waste
    • Non-scheduled waste is domestic waste that is non-hazardous such as papers, plastics and aluminium. In Duopharma, we fully monitor the volume of domestic waste generated and recycled at our sites. We have set a target to recycle 10% of non-scheduled waste generated annually.
  • Waste Thermal Reduction System (Asher) Purchase
    • Asher is an equipment used to burn our non-scheduled/ domestic wastes into ash to reduce the quantity of our waste sent to landfill. This initiative will facilitate the reduction of our company’s carbon emissions (Scope 3).

Management of Climate-related Risks

We recognise the increasing urgent attention to manage climate-related risks throughout our activities and operations. We have put in place climate-related risk management measures to properly assess and adapt to those risks. This includes the requirement to assess any new project on climate-related risks and impacts, prior to its approval and commencement. We have also identified climate-related risks (physical and transitional risk) relevant to our operations, which were subsequently included in Enterprise Risk Management (ERM) for close monitoring and mitigation. Our Board of Directors also provide oversight over climate change in their decision-making processes, where ESG/climate-related risks are included as one of the assessment requirement.